Douglass Hanly Moir Pathology News and Activities

Douglass Hanly Moir Pathology is owned by Sonic Healthcare.

Sonic Healthcare is one of the...

• S&P/ASX200.

Sonic Healthcare is a company listed under the stock ticker SHL (AU).

Sonic Healthcare has a direct presence in 5 countries.

Sonic Healthcare has 10 subsidiaries including Douglass Hanly Moir Pathology, Health Services Laboratories and Sonic Healthcare Australia Pathology.

View the org chart displaying its 15 main executives

Most searched biographies at Douglass Hanly Moir Pathology

• Melanie Galea, Chief Executive Officer
• Graham Beal, Chief Human Resources Officer
• Nick Kodric, Chief Business Development Officer

Popular executive movements at Sonic Healthcare

• Jim Newcombe who is Chief Executive Officer, Douglass Hanly Moir Pathology, will be promoted to Managing Director and Chief Executive Officer on Nov. 20, 2025  (posted on September 26 2025).
• Evangelos Kotsopoulos who is Chief Executive Officer, Sonic Healthcare, Europe and Germany, will become Chief Operating Officer on Nov. 20, 2025  (posted on September 26 2025).
• Colin Goldschmidt, Chief Executive Officer and Managing Director, will retire on Nov. 20, 2025  (posted on September 25 2025).

Click here to view some more movements at Sonic Healthcare

Create your alert
to follow the executive moves at Douglass Hanly Moir Pathology.

Sonic Healthcare has 3,509 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Adaptive Innovations has just announced a $50 Million fundraising (posted on June 4 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Douglass Hanly Moir Pathology

• Dr Newsletter | Douglass Hanly Moir Pathology
• Leadership changes at Douglass Hanly Moir Pathology | Douglass Hanly Moir Pathology
• Changes to Medicare rebate for Active Vitamin B12 testing | Douglass Hanly Moir Pathology
• Updates to fetal Rhesus screening service | Douglass Hanly Moir Pathology

Social media about Douglass Hanly Moir Pathology

• Douglass Hanly Moir Pathology on Wikipedia, Google News & Yahoo Finance
• Douglass Hanly Moir Pathology on LinkedIn, X (Twitter) & YouTube